A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
a study on Breast Cancer
Breast Neoplasms Abemaciclib Abemaciclib Plus (+) Endocrine Therapy (ET)
Lead Scientist at UC Davis
- Helen Chew
Professor, Hematology and Oncology. Authored (or co-authored) 53 research publications.